Exelixis (EXEL) Accounts Payables (2010 - 2026)
Exelixis (EXEL) recorded quarterly Accounts Payables of $24.2 million in Q2 2026, down 18.46% quarter-over-quarter from $29.6 million in Q1 2026, and down 43.62% on a YoY basis from $42.8 million in Q2 2025.
Exelixis (EXEL) Accounts Payables (2010 - 2026) Analysis & Trends
Exelixis' Accounts Payables history runs 17 years deep, the most recent figure standing at $24.2 million for Q2 2026.
- In Q2 2026, Accounts Payables fell 43.62% year-over-year to $24.2 million; the TTM figure through Apr 2026 stood at $24.2 million (down 43.62% YoY), while the FY2026 annual figure was $29.6 million, down 22.43% from the prior year.
- Accounts Payables was $24.2 million for Q2 2026 at Exelixis, down from $29.6 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $59.3 million in Q3 2024 to a low of $17.3 million in Q2 2022.
- Historically, Accounts Payables has averaged $30.6 million across 5 years, with a median of $28.7 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables surged 124.23% in 2024, then slumped 57.26% in 2025.
- A 5-year view of Accounts Payables shows it stood at $32.7 million in 2022, then advanced by 3.37% to $33.8 million in 2023, then surged by 75.64% to $59.3 million in 2024, then plunged by 57.26% to $25.3 million in 2025, then fell by 4.71% to $24.2 million in 2026.
- The last three Accounts Payables figures came in at $24.2 million (Q2 2026), $29.6 million (Q1 2026), and $25.3 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 8.64 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 34.55 Mn |
| 10 | Exelixis | 13.71 Bn | 12.93 Bn | 590.86 Mn | 24.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 24.15 Mn |
| Jan 2, 2026 | 29.62 Mn |
| Oct 3, 2025 | 25.35 Mn |
| Jul 4, 2025 | 25.82 Mn |
| Apr 4, 2025 | 42.84 Mn |
| Jan 3, 2025 | 38.19 Mn |
| Sep 27, 2024 | 59.31 Mn |
| Jun 28, 2024 | 28.68 Mn |
| Mar 29, 2024 | 26.07 Mn |
| Dec 29, 2023 | 33.77 Mn |
| Sep 29, 2023 | 26.45 Mn |
| Jun 30, 2023 | 25.99 Mn |
| Mar 31, 2023 | 32.62 Mn |
| Dec 30, 2022 | 32.67 Mn |
| Sep 30, 2022 | 30.57 Mn |
| Jul 1, 2022 | 19.98 Mn |
| Apr 1, 2022 | 17.29 Mn |
| Dec 31, 2021 | 24.26 Mn |
| Oct 1, 2021 | 24.31 Mn |
| Jul 2, 2021 | 20.45 Mn |